Helicobacter pylori Infection and Insulin Resistance in Diabetic and Nondiabetic Population

Table 2

Insulin resistance, glycemic control, and medication type in patients with respect to seropositivity for HP.

Parameter		HP−	HP+	value
Serum insulin (IU/mL)	Nondiabetic	11.65 ± 4.88	12.71 ± 4.64	0.708
	Diabetic	6.97 ± 2.64	10.12 ± 4.72	0.002
HOMA-IR score	Nondiabetic	2.74 ± 2.18	3.01 ± 2.12	0.704
	Diabetic	3.16 ± 2.32	4.48 ± 2.78	0.013
FBS (mg/dL)	Nondiabetic	92.75 ± 11.70	92.58 ± 14.92	0.915
	Diabetic	173.43 ± 61.32	180.12 ± 64.27	0.468
Lipid profile
HDL (mg/dL)	Nondiabetic	54.23 ± 19.79	56.55 ± 20.05	0.390
	Diabetic	69.2 ± 29.2	60.7 ± 26.7	0.037
LDL (mg/dL)	Nondiabetic	83.26 ± 29.75	85.96 ± 32.67	0.525
	Diabetic	107.1 ± 43.2	116.0 ± 51.7	0.212
TG (mg/dL)	Nondiabetic	142.63 ± 112.27	140.81 ± 95.20	0.897
	Diabetic	224.2 ± 100.2	229.3 ± 114.6	0.747
Cholesterol (mg/dL)	Nondiabetic	161.16 ± 42.68	157.50 ± 38.86	0.509
	Diabetic	205.1 ± 63.2	207.3 ± 67.4	0.8